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Abstract
Peroxiredoxins (Prdxs) are antioxidant enzymes that catalyse the breakdown of peroxides and regulate redox activity in the 
cell. Peroxiredoxin 5 (Prdx5) is a unique member of Prdxs, which displays a wider subcellular distribution and substrate 
specificity and exhibits a different catalytic mechanism when compared to other members of the family. Here, the role of a 
key metabolic integrator coenzyme A (CoA) in modulating the activity of Prdx5 was investigated. We report for the first time 
a novel mode of Prdx5 regulation mediated via covalent and reversible attachment of CoA (CoAlation) in cellular response to 
oxidative and metabolic stress. The site of CoAlation in endogenous Prdx5 was mapped by mass spectrometry to peroxidatic 
cysteine 48. By employing an in vitro CoAlation assay, we showed that Prdx5 peroxidase activity is inhibited by covalent 
interaction with CoA in a dithiothreitol-sensitive manner. Collectively, these results reveal that human Prdx5 is a substrate 
for CoAlation in vitro and in vivo, and provide new insight into metabolic control of redox status in mammalian cells.
Keywords Peroxiredoxin 5 (Prdx5) · Coenzyme A (CoA) · Oxidative stress · Redox regulation · Reactive oxygen species 
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Abbreviations
PRDX5  Peroxiredoxin 5
SBP  Streptavidin binding protein
LC–MS/MS  Liquid chromatography tandem-mass 
spectrometry
Introduction
Peroxiredoxins (Prdxs) are antioxidant enzymes that neu-
tralise a broad range of reactive oxygen and nitrogen spe-
cies, including  H2O2, alkyl hydroperoxides and peroxyni-
trites. Prdxs are highly conserved throughout evolution and 
broadly distributed from bacteria to humans [1, 2]. The fam-
ily of mammalian Prdxs can be subdivided into three major 
subclasses based on sequence, structural homology and cata-
lytic mechanism: typical 2-cysteine (2-Cys) Prdxs (Prdxs1-
4), atypical 2-Cys Prdx (Prdx5) and 1-Cys Prdx (Prdx6). 
Prdxs exhibit different subcellular localisation, regulation 
and substrate specificity. All members of the Prdx family 
share a common mechanism of peroxide-reducing activity 
that involves oxidation of a conserved peroxidatic cysteine 
(CysP) to a sulphenic acid (R-SOH), but differ in the mode 
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of its reduction back to a thiol. The activity and cellular 
functions of Prdxs are tightly controlled by regulatory 
interactions and post-translational modifications. A diverse 
range of binding partners for Prdxs have been identified, 
including proteins involved in signal transduction, metabolic 
processes and antioxidant defence [3–5]. Reversible thiol 
modifications, including S-sulphenylation, S-sulphinylation, 
S-glutathionylation and S-nitrosylation, as well as phospho-
rylation and acetylation were shown to play key roles in 
regulating peroxidase activity, subcellular localisation and 
redox signalling of Prdx family members [3–6]. By regulat-
ing intracellular peroxide levels, Prdxs were shown to par-
ticipate in the regulation of cell proliferation, differentiation 
and redox signalling under physiological and pathological 
conditions [1, 7, 8].
Prdx5 is the most divergent isoform among mammalian 
peroxiredoxins and shows a surprisingly wide subcellu-
lar distribution, including the mitochondria, peroxisomes, 
nucleus and cytoplasm [6]. The catalytic mechanism of 
Prdx5 is initiated by the reduction of a peroxide substrate, 
during which the peroxidatic Cys48 thiol (Cys48-SH) is 
oxidised to sulphenic acid (Cys48-SOH). The resolving 
Cys152 then reacts with Cys48-SOH to form an intramolec-
ular disulphide. Due to the large distance between Cys152-
SH and Cys48-SOH, the enzyme undergoes a significant 
conformational change to allow the two groups to come 
into proximity. Thioredoxins (Trx1 in the cytosol or Trx2 
in the mitochondria) reduce the disulphide bond (Cys48-
SS-Cys152) and regenerate a sulfhydryl group on Cys48, 
thereby reactivating the enzyme. This reaction requires the 
reductant NADPH, which is used by thioredoxin reductase 
(TrxR) to regenerate Trxs.
Consistent with its antioxidant properties, the knock-
down of Prdx5 makes cells more susceptible to apoptosis 
induced by oxidative stress, while its overexpression pre-
vents programmed cell death [9]. Transcriptional or trans-
lational upregulation or downregulation of the Prdx5 gene 
was shown to take place in response to various stresses and 
during pathophysiological conditions such as cancer [7].
Coenzyme A (CoA) is an obligatory cofactor in all living 
cells synthesised from pantothenate (Vitamin B5), adeno-
sine triphosphate (ATP) and cysteine [10]. CoA and its thi-
oester derivatives (acetyl CoA, malonyl CoA and succinyl 
CoA among many others) are key players in major catabolic 
and anabolic pathways and the regulation of gene expres-
sion [10–13]. Many human pathologies, including cancer, 
diabetes and neurodegeneration, have been associated with 
abnormal biosynthesis and homeostasis of CoA and its 
derivatives [14–16].
We have recently discovered a novel non-canonical func-
tion of CoA in redox regulation, involving covalent attach-
ment of this coenzyme to cellular proteins in response to 
oxidative and metabolic stress, termed protein CoAlation. 
The development of new research tools and methodologies 
has been instrumental in uncovering protein CoAlation as 
a widespread post-translational modification and revealing 
its role in redox regulation. These developments afford us 
the unique opportunity to readily detect protein CoAlation 
in eukaryotic and prokaryotic cells in response to oxida-
tive and metabolic stress and identify CoAlated proteins. 
To date, nearly one thousand proteins have been found to 
be CoAlated in bacteria, mammalian cells and tissues in 
response to oxidising agents and metabolic stress [17, 18].
Here, we report for the first time that Prdx5 is covalently 
modified by CoA when cells and tissues are exposed to 
oxidative and metabolic stress. Mass spectrometry analysis 
revealed that the peroxidatic Cys48 is CoAlated in cellular 
response to oxidative stress. We demonstrated by employing 
an in vitro CoAlation assay that covalent binding of CoA 
to Prdx5 results in complete inhibition of its peroxidase 
activity, which is reversed by reduction with DTT. Based 
on these findings, we propose that covalent modification of 
peroxidatic cysteine 48 in Prdx5 in response to oxidative and 
metabolic stress not only protects it from overoxidation but 
may function as regulatory mechanism of redox signalling.
Materials and methods
All common chemicals were obtained from Sigma–Aldrich 
unless otherwise stated. The generation and characterisation 
of the anti-CoA antibody (1F10) was described previously 
[19]. Anti-Prdx5 rabbit antibody were obtained from Abcam 
and secondary Alexa Fluor 680 goat polyclonal anti-mouse 
IgG and Alexa Fluor 800 goat polyclonal anti-rabbit IgG 
were from Life Technologies.
Cell culture
HEK293/Pank1β cells were generated as previously 
described [17]. Cells were maintained in DMEM (Lonza) 
supplemented with 10% foetal bovine serum (FBS, Hyclone) 
and 10 ml/L Penicillin–streptomycin (P/S, Lonza).
Cardiomyocytes preparation
Cardiomyocytes were isolated from adult male Wistar rats 
weighing 300–350 g. Primary cardiomyocytes were iso-
lated as previously described with minor changes [20]. The 
isolated cardiomyocytes were suspended in M199 media 
(ZenBio) supplemented with 5 mmol/l creatine, 5 mmol/l 
taurine, 2 mmol/l carnitine, 100 IU/ml penicillin and 100 IU/
ml streptomycin, then plated on 6 cm dishes (VWR UK) pre-
coated with 5 mcg/ml laminin. Cells were plated at a density 
of 340.000 rod-shaped cells per dish and incubated over-
night at 37 °C and 5%  CO2 before experiments the following 
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day. > 90% of attached cells appeared to be rod-shaped and 
non-contracting.
Plasmids and transient transfection
Human Prdx5 cDNA without the signal sequence was cloned 
into the pCR3.1/Prdx5 vector as previously described [21]. 
HEK293/Pank1β cells were transfected at ~ 60% confluence 
with pCR3.1-MAR plasmid vectors encoding streptavidin 
binding protein (SBP); SBP-tagged full-length WT-hPrdx5, 
hPrdx5C48S, hPrdx5C152S and hPrdx5C48/152S. Cells 
were transfected according to the manufacturer’s protocol 
using Turbofect reagent (Thermo Scientific).
Oxidative and metabolic stress induction
Following transient transfection or an overnight sub-cultur-
ing, cells were incubated for 18 h in pyruvate-free DMEM 
supplemented with 5 mM glucose, 10% FBS and 10 ml/L 
P/S. Pyruvate was removed from the media because it can 
act as an antioxidant and inactivate ROS. Cells were then 
treated with or without  H2O2 (500 μM), diamide (500 μM) 
or menadione (50 μM), and incubated for 30 min at 37 °C. 
To induce metabolic stress, the medium of transiently trans-
fected cells was replaced with pyruvate- and glucose-free 
DMEM and cells were incubated for an additional 18 h. To 
allow recovery, full DMEM media was re-introduced after 
18 h and cells were incubated in at 37 °C for 30 min.
Cell lysis, immunoprecipitation and western blot 
analysis
Harvested cells were lysed for 20 min in lysis buffer (at 4 °C) 
containing 50 mM Tris–HCl pH 7.5, 150 mM NaCl, 5 mM 
ethylenediaminetetraacetic acid (EDTA), 50 mM sodium flu-
oride (NaF), 5 mM tetra-sodium pyrophosphate  (Na4P2O7) 
and 1% Triton X-100, supplemented with fresh 100 mM 
NEM and fresh 1 × Protease Inhibitor Cocktail (PIC, Roche). 
Total cell lysates were centrifuged at 20,817×g for 10 min at 
4 °C and the supernatant was collected for further analysis. 
Protein concentration was measured using the Bicinchoninic 
acid Protein Assay Kit (Thermo Scientific). Immunoprecipi-
tation of endogenous Prdx5 from cell lysates was carried 
out using Protein G Sepharose (Generon) and anti-Prdx5 
antibody. Affinity purification of SBP-Prdx5 was carried out 
using streptavidin beads (Upstate Biotechnology Inc). Pro-
teins were eluted with 2× SDS loading buffer and analysed 
by anti-CoA Western blots. SDS-PAGE separated proteins 
were transferred to a PVDF membrane (Bio-Rad Laborato-
ries) which was then blocked with Odyssey blocking buffer. 
The membrane was incubated in primary antibodies for 2 h 
at room temperature (RT) or overnight at 4 °C, and with 
secondary antibodies for 30 min RT. Immunoreactive bands 
were visualised using Odyssey Scanner CLx and Image Stu-
dio Lite software (LI-COR Biosciences).
Heart perfusion
Sprague–Dawley rats (120–300 g) were used in this study. 
All experiments involving animals were performed in 
accordance with the European Convention for the Protection 
of Vertebrate Animals used for Experimental and Other Sci-
entific Purposes (CETS no. 123) and the UK Animals (Sci-
entific Procedures) Act 1986 amendment regulations 2012. 
Heart perfusion was performed as previously described, with 
minor modifications. BSA was omitted and 11 mM glucose 
and 1.8 mM  CaCl2 were added to Krebs–Henseleit buffer 
(KHB) [22]. Hearts were perfused with KHB for 10 min 
followed by 20 min perfusion in the presence or absence of 
100 µM  H2O2.
Expression and affinity purification of Prdx5
Escherichia coli BLR (DE3) cells were transformed with 
plasmid containing His-tagged human Prdx5 coding 
sequence [21]. Expression and affinity purification of His-
Prdx5 on Talon Resin (Clontech Laboratories) was per-
formed as described previously [23]. Eluted protein was 
dialysed against 20 mM Tris–HCl (pH 7.5) containing 1 mM 
EDTA and stored at − 80 °C.
In vitro CoAlation assay
Purified recombinant His-Prdx5 (0.5 µg) was incubated with 
a mixture of oxidised and reduced forms of CoA (CoASH 
and CoASSCoA, 1 mM final) in 20 mM Tris–HCl, pH 7.5 
for 30 min at RT. The mixture was passed through a Bio-
Spin 6 column (Bio-Rad) to remove excess CoA, and this 
preparation of Prdx5 was further used in activity assays. For 
Western blot analysis, NEM (10 mM final) was added to the 
samples for 10 min before mixing with SDS loading buffer 
(1× final) with or without DTT.
For SDS-PAGE analysis, 2 µg of His-Prdx5 was incu-
bated with CoA and CoASSCoA as previously described, or 
with  H2O2 (1 mM final) for 10 min or with buffer alone, and 
was mixed with reducing or non-reducing loading buffer, 
before loading on the gel.
Prdx5 activity assay
Prdx5 activity was measured using the thioredoxin system 
as described previously [24]. The rate of  H2O2 degradation 
was measured by monitoring the decrease in A340 caused 
by NADPH oxidation. The assay was performed in a 
150 μl reaction mixture, containing 50 mM Hepes–NaOH 
(pH 7), 200 μM NADPH, 760 nM mouse TrxR, 11 μM 
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human Trx and 1 μM Prdx5 (control or in vitro CoAlated). 
The mix was incubated at 37 °C for 5 min, and the reaction 
initiated by the addition of 500 μM  H2O2.
Statistical analysis
Where appropriate, values are given as means ± SEM.
Mass spectrometry and data processing
Peptides resulting from enzymatic digestion were analysed 
by nano-scale capillary LC–MS/MS using an Ultimate 
U3000 UPLC System (Dionex) fitted with a 100 µm × 2 cm 
PepMap100  C18 nano trap column and a 75 μm × 25 cm 
PepMap100  C18 nano analytical column (Dionex). Pep-
tides were eluted using an acetonitrile gradient and sprayed 
directly via a nano-flow electrospray ionisation source 
into the mass spectrometer (Orbitrap Velos, Thermo 
Scientific). The mass spectrometer was operated in data 
dependent mode, using a full scan (m/z = 350–1600) 
in the Orbitrap analyser, with a resolution of 60,000 at 
m/z = 400, followed by MS/MS acquisitions of the 20 most 
intense ions in the LTQ Velos ion trap. Maximum FTMS 
scan accumulation times were set at 250 ms and maxi-
mum ion trap MSn scan accumulation times were set at 
200 ms. The Orbitrap measurements were internally cali-
brated using the lock mass of polydimethylcyclosiloxane at 
m/z 445.120025. Dynamic exclusion was set for 30 s with 
exclusion list of 500. LC–MS/MS raw data files were pro-
cessed as standard samples using MaxQuant [25] version 
1.5.2.8 which incorporates the Andromeda search engine. 
MaxQuant processed data were searched against either a 
Rat or Human UniProt protein database. Carbamidomethyl 
cysteine, Acetyl N-terminal, N-ethylmaleimide cysteine, 
oxidation of methionines, CoAlation of cysteine with delta 
mass 338, 356 and 765, were set as variable modifications. 
For all data sets, the default parameters in MaxQuant were 
used, except MS/MS tolerance, which was set at 0.6 Da 
and the second peptide ID was unselected.
Results
Mass spectrometry‑based identification of Prdx5 
CoAlation
To study the role of CoA in redox regulation in mamma-
lian cell and tissues, we employed the HEK293/Pank1β 
cell and Langendorff-perfused heart models. HEK293/
Pank1β cells were grown to 60% confluency in complete 
Dulbecco’s modified Eagle’s medium (DMEM) and then 
cultured in pyruvate-free, low glucose DMEM for 18 h. 
Oxidative stress was induced by incubating cells in the 
presence of 500 µM  H2O2 or 500 µM diamide for 30 min. 
Protein extracts were separated on non-reducing SDS-
PAGE and immunoblotted with anti-CoA monoclonal 
antibody. As shown in Fig. 1a, only a few proteins are 
CoAlated at a background level in control non-treated 
cells, while extensive protein CoAlation is observed in 
response to  H2O2 and diamide.
In addition, we used the Langendorff-perfused heart 
model for examining protein CoAlation in rat heart 
exposed to oxidative stress. In this study, isolated rat 
hearts were perfused with 100 µM  H2O2 for 20 min and 
homogenised as described in Materials and Methods. We 
found that  H2O2 perfusion significantly increased pro-
tein CoAlation when compared to control, and this was 
reversed to the level of untreated control by DTT (Fig. 1b).
Extensive protein CoAlation in response to oxida-
tive stress in HEK293/Pank1β and perfused rat heart 
prompted us to identify CoA-modified proteins using 
the developed methodology [17]. In our studies, we used 
HEK293/Pank1β cells which overexpress pantothenate 
kinase 1β (the main rate-limiting enzyme in CoA biosyn-
thesis) and produce comparable levels of CoA as those 
found in rat heart, liver, kidney or primary cardiomyo-
cytes. In fact, analysis showed that established cell lines 
HepG2 and HEK293 contain much lower concentrations 
of CoA when compared to those found in the previously 
mentioned sources [26]. A diverse range of proteins was 
found to be CoAlated in prepared samples from HEK293/
Pank1β cells and perfused rat heart. The vast majority of 
CoAlated proteins were found to be involved in metabolic 
processes (over 65%), as well as proteins implicated in 
stress response. Notably, an atypical member of the per-
oxiredoxin family, Prdx5, was found to be CoAlated at 
peroxidatic Cys48 in both HEK293/Pank1β cells and 
perfused rat heart exposed to  H2O2. Figure 1c shows the 
liquid chromatography tandem-mass spectrometry spec-
trum of a cysteine-containing peptide derived from Prdx5 
(GVLFGVPGAFTPGCSK) with an increase in 356 Da, 
corresponding to covalently attached 4-phosphopanteth-
eine to cysteine residue.
Fig. 1  Prdx5 is CoAlated in HEK293/Pank1β cells and in per-
fused rat heart in response to oxidative stress. a Anti-CoA West-
ern blot reveals extensive modification of cellular proteins by CoA 
in HEK293/Pank1β cells treated with 500  µM  H2O2 and 500  µM 
diamide for 30 min. b Analysis of protein CoAlation in isolated rat 
hearts perfused in the presence or absence of 100  µM  H2O2 for 20 
min, N = 3. c LC–MS/MS spectrum of a CoAlated peptide (GVLF-
GVPGAFTPGCSK), corresponding to peroxiredoxin 5 (Prdx5). The 
Prdx5-derived peptide was immunoprecipitated with anti-CoA anti-
body 1F10 from trypsin/LysC digested protein extracts of rat heart 
perfused with 100 µM  H2O2 and analysed by LC–MS/MS as previ-
ously described (Y. Tsuchiya et al.)
◂
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Prdx5 CoAlation is induced in cells by a panel 
of oxidising agents
Induction of Prdx5 CoAlation by  H2O2 in both experimen-
tal models prompted us to examine whether Prdx5 is CoA-
lated in cellular response to other oxidising agents. In this 
study, cells were transfected with pCR3.1-MAR/wt-Prdx5 
plasmid, which drives the expression of human Prdx5 
with the N-terminally tagged streptavidin binding peptide 
(SBP). Transfected cells were grown in pyruvate-free and 
low glucose media for 18 h and then treated with or without 
500 µM  H2O2, 500 µM diamide or 50 µM menadione for 
30 min to induce oxidative stress. Transiently overexpressed 
SBP-Prdx5 was pulled down from cell lysates using strepta-
vidin beads and both total and the pulled down proteins 
were analysed by SDS-PAGE under non-reducing condi-
tions followed by immunoblotting with anti-CoA antibody. 
As shown in Fig. 2a, treatment of cells with  H2O2, diamide 
and menadione induces extensive modification of cellular 
proteins by CoA in examined total protein extracts. Weak 
background immunoreactive signal was observed in control 
untreated cells. Immunoblotting of pulled down SBP-Prdx5 
revealed strong induction of Prdx5 CoAlation in cells treated 
with all oxidising agents, and the highest level is observed 
in response to diamide treatment (Fig. 2b).
To further validate the above findings, we examined 
CoAlation of endogenous Prdx5 from HEK293/Pank1β 
cells or primary rat cardiomyocytes treated or untreated 
with 500 μM diamide for 30 min. Endogenous Prdx5 was 
immunoprecipitated from total cell lysates with anti-Prdx5 
antibody and the immune complexes probed with anti-CoA 
and anti-Prdx5 antibodies. The induction of endogenous 
Prdx5 CoAlation in response to diamide treatment is shown 
in Fig. 2c, d.
Prdx5 CoAlation is induced by glucose deprivation
Glucose is the primary source of energy in most eukaryotic 
cells and glucose deprivation causes metabolic oxidative 
stress. The observation that culturing HEK293/Pank1β cells 
in pyruvate-free and low glucose medium resulted in sub-
tle increase of CoAlated Prdx5 (Fig. 2c), led us to examine 
the effect of metabolic stress induced by glucose depriva-
tion on Prdx5 CoAlation. Here, HEK293/Pank1β cells were 
transfected with pCR3.1-MAR/wt-Prdx5 plasmid and, 24 h 
later, the transfection medium was replaced with pyruvate- 
and glucose-free DMEM. Cells were harvested after 18 h 
and total protein extracts and streptavidin-Sepharose pulled 
down proteins were analysed by immunoblotting with anti-
CoA antibody.
As shown in Fig. 3a, significant increase in protein CoA-
lation was observed in cells cultured in glucose-deprived 
media. Notably, adding full media back to metabolically 
stressed cells for 30 min resulted in significant de-CoAlation 
of cellular proteins, which was almost at the level of control 
cells. Immunoblotting of streptavidin-Sepharose pull-down 
complexes with anti-CoA antibodies revealed markedly 
increased CoAlation of SBP-Prdx5 in glucose-deprived cells 
(Fig. 3b). A background level of SBP-Prdx5 CoAlation was 
observed in control cells. To find out whether the induc-
tion of SBP-Prdx5 CoAlation by glucose deprivation is a 
reversible post-translational modification, complete media 
was re-introduced for 30 min. As shown in Fig. 3b, glucose 
deprivation-induced Prdx5 CoAlation is completely reversed 
after the re-addition of complete DMEM medium.
Mutational analysis of Prdx5 CoAlation in response 
to oxidative and metabolic stress
Prdx5 possesses three cysteine residues: Cys48 and 
Cys152 correspond to peroxidatic and resolving cysteines 
respectively, while Cys73 is not involved in the catalytic 
Fig. 2  CoAlation of endogenous and transiently overexpressed Prdx5 
is induced in response to oxidising agents. a Western blot analysis of 
protein CoAlation in HEK293/Pank1β cells treated for 30  min with 
diamide (500 µM), menadione (50 µM) or  H2O2 (500 µM). b Tran-
siently overexpressed SBP-tagged Prdx5 was pulled down from cell 
lysates and bound proteins examined by immunoblotting with anti-
CoA antibodies. c Western blot analysis of immunoprecipitated 
endogenous Prdx5 from HEK293/Pank1β cells or primary cardiomy-
ocytes d treated or not treated with 500 µM diamide for 30 min. N = 3
Molecular and Cellular Biochemistry 
1 3
mechanism [23]. The LC–MS/MS analysis revealed CoA-
lation of peroxidatic Cys48 in HEK293/Pank1β cells and 
perfused rat heart exposed to  H2O2. To validate this find-
ing and investigate whether other cysteine residues are 
covalently modified by CoA under oxidative and metabolic 
stress, we carried out mutational studies using a panel of 
hPrdx5 mutants (C48S, C152S or C48/152S). Initially, we 
examined at which site/sites Prdx5 is CoAlated under oxi-
dative stress. Here, HEK293/Pank1β cells were transfected 
with pCR3.1-MAR plasmids, expressing wild type or gen-
erated mutants of Prdx5. 24 h after transfection, cells were 
incubated for 30 min with or without 500 µM diamide. 
Streptavidin pull-downs from lysed cells were analysed by 
Western blotting with anti-CoA and anti-Prdx5 antibodies. 
The anti-Prdx5 blot shows a comparable amount of pulled 
down SBP-Prdx5 in all transfected cells. Diamide-induced 
CoAlation of wtPrdx5 is readily detected in anti-CoA blot 
of streptavidin pull-downs (Fig. 4a and b). The C48S and 
C152S mutants were also CoAlated, but at a reduced level, 
suggesting CoAlation of both peroxidatic and resolving 
cysteines in cellular response to oxidative stress. This 
assumption was confirmed when we examined diamide-
induced CoAlation of the C48/152S double mutant. As 
shown in Fig. 4b, the C48/152S double mutant is not CoA-
lated in control and diamide-treated cells. These findings 
also indicate that the non-catalytic Cys73 is not CoAlated 
in cells exposed to oxidising agents.
We also investigated CoAlation of transiently overex-
pressed wild type and cysteine mutants of SBP-Prdx5 in 
HEK293/Pank1β cells under metabolic stress induced by 
glucose deprivation. Immunoblotting of streptavidin-Sepha-
rose pulled down proteins with anti-CoA antibody showed 
background CoAlation in control cells (Fig. 4c and d). As 
expected, significant CoAlation of transiently expressed 
wtPrdx5 was detected in glucose-deprived cells. Similar to 
diamide-treated cells, CoAlation of the C48S and C152S 
mutants was significantly lower, when compared to wtPrdx5 
(Fig. 4c and d). No CoAlation of the C48/152S double 
mutant was observed in glucose-deprived cells.
Peroxidase activity of Prdx5 is inhibited by covalent 
binding of CoA in vitro
We have recently developed an in vitro CoAlation assay, 
which allows covalent CoA modification of purified recom-
binant and endogenous proteins with high efficiency [17]. 
Using this assay, we showed that in vitro CoAlation of sev-
eral enzymes from different metabolic pathways, including 
creatine kinase (CK) and glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH), results in significant inhibition of their 
enzymatic activities [17].
To test the effect of CoAlation on Prdx5 peroxidase activ-
ity, recombinant His-Prdx5 was incubated with or without a 
mix of CoASH (reduced) and CoASSCoA (oxidised) in the 
CoAlation buffer for 30 min. Then, the reaction mixture was 
passed through a BioSpin column to remove the excess of 
reduced and oxidised CoA. The efficiency of in vitro CoA-
lation was confirmed by Western blotting with anti-CoA 
antibody. As shown on Fig. 5a, recombinant His-Prdx5 was 
modified by CoA in vitro in a DTT-sensitive manner. Prdx5 
activity towards  H2O2 was then assayed by measuring the 
decrease in NADPH absorbance at 340 nm as described in 
M&M. Figure 5b demonstrates that in vitro CoAlation of 
His-Prdx5 results in near complete inhibition (98.7%) of 
the peroxidase activity. Furthermore, the inhibitory effect 
of CoAlation on Prdx5 activity was efficiently reversed by 
the addition of 100 mM DTT to the reaction mix. These data 
indicate that covalent modification of catalytic cysteines by 
CoA results in the inhibition of Prdx5 peroxidase activity 
and the inhibitory effect is reversed by the reducing power 
of DTT.
We also examined electrophoretic mobility of control 
(untreated), oxidised  (H2O2 treated) and CoAlated His-
Prdx5 separated under reducing and non-reducing con-
ditions. This analysis showed that control, oxidised and 
CoAlated His-Prdx5 run as a single band of ~ 20 kDa under 
reducing conditions (Fig. 5c). However, different pattern of 
electrophoretic mobility was observed under non-reducing 
Fig. 3  CoAlation of transiently overexpressed Prdx5 in HEK293/
Pank1β cells is induced by metabolic stress. HEK293/Pank1β cells 
were grown in pyruvate and glucose-free media for 18  h to induce 
metabolic stress. To find whether Prdx5 CoAlation is a reversible 
post-translational modification, complete media was then re-intro-
duced for 30 min (recovery lane). Total protein (a) or SBP-Prdx5 (b) 
CoAlation was analysed by anti-CoA immunoblot. N = 3
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conditions. In vitro CoAlated Prdx5 showed the same mobil-
ity under reducing and non-reducing conditions (~ 20 kDa). 
The exposure of recombinant His-Prdx5 to  H2O2 results in 
faster mobility (~ 18 kDa) under non-reducing conditions, 
suggesting significant conformational changes in a mono-
meric form of Prdx5 mediated by a disulphide bond forma-
tion. These findings are in agreement with published crys-
tallographic studies of reduced and oxidised forms of Prdx5 
[23, 24]. The distance between the two sulphur atoms of 
peroxidatic Cys48 and resolving Cys152 in a reduced form 
of Prdx5 is 13.8 A° [24]. The overall fold of oxidised Prdx5 
is very similar to that of the reduced form and the main con-
formational changes involve the movement of the regions 
containing peroxidatic and resolving cysteines, allowing the 
formation of a disulphide bridge and a more compact fold 
[23]. A significant proportion of control His-Prdx5, which 
was stored at − 20 °C in buffer without DTT, also runs with 
higher electrophoretic mobility. These data indicate that 
recombinant Prdx5 is prone to oxidation when stored with-
out DTT even for a short period of time. It has been reported 
that freshly grown Prdx5 crystals can only survive for a few 
days when they are simply exposed to air, whereas crystals 
of the C48S mutant are much more stable, even in presence 
of  H2O2 [24].
It has been reported that PRDX5 can also form dimers, 
known as type A dimers, and most contacts involve hydro-
phobic interactions with the exception of an inter-molecu-
lar salt bridge between Arg124 and Asp77 [23]. A minor 
percentage of dimeric (~ 40 kDa) and potentially trimeric 
(~ 60 kDa) forms of Prdx5 was observed under non-reducing 
conditions, and their appearance is DTT-dependent (Fig. 5c).
Discussion
Prdx5 was the last mammalian isoform of the Prdx fam-
ily to be identified and therefore, the knowledge on its 
regulation by signalling pathways via binding partners and 
post-translational modifications is lagging. To date, several 
post-translational modifications of Prdx5, including phos-
phorylation, acetylation and glutathionylation, have been 
reported in proteome-wide studies, but their physiological 
relevance remains unclear [27–29]. Interestingly, glutathio-
nylation of Prdx5 was detected by MALDI-MS in primary 
rat hepatocytes exposed to oxidative stress. However, the 
site of glutathionylation and significance of this modifica-
tion in the regulation of Prdx5 catalytic activity has yet to 
be investigated [28].
Fig. 4  Mutational analysis of 
Prdx5 CoAlation in cellular 
response to oxidative and 
metabolic stress. a HEK293/
Pank1β cells transfected with 
wild type (WT) and C48S 
mutant of SBP-Prdx5 were 
incubated with and without 
500 µM diamide for 30 min; b 
HEK293/Pank1β cells trans-
fected with wild type, C152S 
and C48/152S mutants of 
SBP-Prdx5 were incubated with 
or without 500 µM diamide for 
30 min. c, d HEK293/Pank1β 
cells transfected with wild type 
and mutants of SBP-Prdx5 were 
grown in pyruvate (pyr) and 
glucose (glu) free media for 
18 h to induce metabolic stress. 
Transiently overexpressed 
SBP-tagged WT Prdx5, C48S, 
C152S and C48/152S mutants 
were pulled down with Strepta-
vidin beads and examined by 
anti-CoA immunoblot. N = 3
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In this paper, we report for the first-time covalent modi-
fication of Prdx5 by CoA in cellular response to oxidative 
and metabolic stress. Evidence is provided that Prdx5 is 
CoAlated at low background level in exponentially growing 
cells, while exposure to oxidising agents induces covalent 
modification of transiently overexpressed and endogenous 
Prdx5 by CoA. Furthermore, metabolic stress induced by 
glucose deprivation also leads to a significant increase in 
Prdx5 CoAlation, which is efficiently reversed by the re-
addition of glucose to the culture medium. These findings 
are in agreement with our recently published studies on 
redox regulation of protein CoAlation in prokaryotic and 
eukaryotic cells [17, 18].
Human Prdx5 and orthologues in vertebrates and inver-
tebrates possess three highly conserved cysteine residues: 
Cys48, Cys73 and Cys152. Crystallographic studies of 
hPrdx5 in reduced and oxidised states revealed that both per-
oxidatic Cys48 and resolving Cys152 are surface exposed, 
while Cys73 is completely buried [23, 24]. The LC–MS/MS 
analysis of CoAlated proteins in HEK293/Pank1β cells and 
Fig. 5  Regulation of the Prdx5 enzymatic cycle by CoAlation a 
In vitro CoAlted-Prdx5 was boiled in loading buffer with or without 
DTT. CoAlation of Prdx5 was examined by anti-CoA immunoblot. 
b NADPH oxidation coupled to the peroxidase activity of Prdx5 in 
the presence of the Trx systems. The initial rate of NADPH oxida-
tion was monitored by measurement of the decrease in A340 in the 
presence of Prdx5 at 37  °C. The 150  μl reaction mixture contained 
50 mM Hepes–NaOH (pH 7), 200 μM NADPH, 76 nM mouse TrxR, 
1.1 μM human Trx, and 2 μg untreated Prdx5 (control), in vitro CoA-
lated Prdx5 or in vitro CoAlated Prdx5 with DTT. The reaction was 
initiated by the addition of 0.5 mM  H2O2. c Recombinant Prdx5 was 
incubated with oxidised and reduced CoA or with  H2O2 for 30 min, 
or with buffer (Prdx5 alone). The samples were separated by SDS-
PAGE under reducing (+DTT), and non-reducing conditions (-DTT). 
The arrows indicate the position of monomeric and dimeric forms of 
His-Prdx5. d Schematic representation of the Prdx5 catalytic cycle. 
In the presence of a substrate molecule, Prdx5 peroxidatic cysteine 
is oxidised to sulphenic acid (Cys-SOH) and condenses to form an 
intramolecular disulphide with the resolving cysteine. In prolonged 
oxidative or metabolic stress conditions, the CoA thiol attacks the 
cysteine sulphenic acid, or disulphide bond and binds to catalytic 
Cys48
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perfused rat hearts exposed to  H2O2 revealed CoAlation of 
only the peroxidatic Cys48. The peroxidatic cysteines are 
more nucleophilic and highly sensitive to attack by reac-
tive oxygen and reactive nitrogen species, and therefore 
are more prone to regulatory S-thiolation, than resolving 
cysteine residues. The peroxidatic Cys48 in hPrdx5 has a 
low pKa (5.2), making it deprotonated at physiological pH 
and more nucleophilic [29]. In normal metabolic condi-
tions, the peroxidatic cysteine residue of Prdx5 reduces a 
peroxide substrate and is oxidised to sulphenic acid. The 
resolving Cys152 then attacks this cysteine sulphenic acid 
forming an intramolecular disulphide bond, which is reduced 
by thioredoxin to regenerate an active enzyme. Thioredoxin 
reductase reduces the oxidised thioredoxin, using NADPH 
as a reductant. In conditions of severe oxidative stress or 
prolonged metabolic stress, NADPH is depleted and there-
fore the NADPH-dependent recycling system for Prdx5 
might not function efficiently to reduce the intramolecular 
disulphide bond of oxidised Prdx5. We hypothesise that the 
CoA thiol attacks the Cys48 cysteine sulphenic acid, or the 
disulphide bond formed between the peroxidatic Cys48 and 
the resolving Cys152, and binds to protect the peroxidatic 
Cys48 from overoxidation. Indeed, it was shown in previous 
studies that treatment of cells with 100–200 µM peroxides 
(t-butyl hydroperoxide,  H2O2) is sufficient to cause over-
oxidation of Prdxs [30–32]. CoAlation of Prdx5 might be 
a regulatory event to protect the catalytic Cys48 from irre-
versible overoxidation. In mutational studies we observed 
oxidative and metabolic stress-induced CoAlation of both 
peroxidatic Cys48 and resolving Cys152. We speculate that 
in wild type Prdx5, peroxidatic Cys48 is a preferred target 
for the oxidation-mediated covalent modification by CoA, 
while CoAlation of resolving Cys152 is a specific attribute 
of the Prdx5C48S mutant. Covalent modification of peroxi-
datic Cys48 by CoA implies the inhibitory effect of CoAla-
tion on Prdx5 peroxidase activity. Indeed, in vitro CoAlated 
recombinant Prdx5 was found to be enzymatically inactive 
and the peroxidase activity was recovered by DTT-mediated 
dissociation of CoA. Our studies in metabolic stress showed 
that CoAlation of Prdx5 is physiologically reversible, and we 
have proposed the existence of CoA-redoxins that would act 
to reduce CoA-modified proteins [33].
These results are in agreement with our previous 
studies, in which we demonstrated that in vitro CoAla-
tion of catalytically active cysteines in several metabolic 
enzymes, including CK, pyruvate dehydrogenase kinase 
2 (PDK2) and GAPDH, impedes their catalytic activities 
and the inhibition is DTT-sensitive [17]. Furthermore, we 
have also demonstrated that in vitro CoAlation of Staphy-
lococcus aureus GAPDH not only inhibits the enzymatic 
activity, but also protects the catalytic Cys151 from over-
oxidation by  H2O2 [18]. The question which remains to 
be answered is whether redox-induced Prdx5 CoAlation 
serves to protect catalytic cysteines from overoxidation 
and to upregulate the antioxidant defence via redox sig-
nalling. Recently, glutathionylation of Prdx2 under oxida-
tive stress conditions was shown to protect the catalytic 
cysteines from hyperoxidation and play a role in redox 
signalling [34, 35].
The attachment of pantetheine and 3′5′-ADP moieties to 
CoA-modified cysteines in oxidative stress response may 
generate a unique binding motif for intra- and inter-molec-
ular interactions, especially for proteins containing the 
nucleotide binding fold. It has been recently reported that 
redox-mediated modification of Prdx1 by GSH induces 
its interaction with phosphatase and tensin homolog 
(PTEN) and mammalian Ste20-like kinase-1 (MST1) in 
the regulation of pro-survival signalling and the cell cycle 
respectively [36, 37]. We speculate that Prdx5 CoAlation 
in cellular response to oxidative and metabolic stress may 
promote the formation or dissociation of regulatory com-
plexes, which are involved in redox signalling and anti-
oxidant defence. Recently, specific interaction between 
superoxide dismutase 1 (SOD1) and Prdx5 was shown to 
be critical for maintaining mitochondrial redox homeosta-
sis and avoiding cell death [38]. It will be interesting to 
investigate whether the SOD1/Prdx5 interaction is affected 
by covalent modification of Prdx5 catalytic cysteines in 
cellular response to oxidative and metabolic stress.
Taken together, the findings presented in this study 
permit us to propose that the Prdx5 catalytic cycle oper-
ates when permissible levels of  H2O2 are produced in cells 
under oxidative stress (Fig. 5c). Further accumulation of 
 H2O2 can induce Prdx5 CoAlation, which may function to 
protect catalytic cysteines from overoxidation and initiate 
redox signalling pathways involved in antioxidant defences 
and the repair of oxidative damage.
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